Search

All phases Early Phase 1 Phase 1 Phase 2 Phase 3 Phase 4 Phase 1/2 Phase 2/3

All statuses Open (recruiting or opening soon) Active, not recruiting Completed

25 miles 50 miles 100 miles 200 miles

Newest Nearest Most relevant

Apply Reset

Multiple Objective Particle Swarm Optimization Postural Instability Gait Disorder

Trial Early Phase 1 Recruiting May 7, 2026

Changes in Movement, Fitness, and Quality of Life in People With Parkinson's Disease After Different Exercise Programs

Trial N/A Recruiting May 7, 2026

Probiotic Treatment for Depression and Associated Mood Disorders in Parkinson's Disease

Trial Phase 2 Recruiting May 7, 2026

Impact of Force Control of Hip Abductor Muscles in Healthy Adults and Individuals With Parkinson's Disease

Trial N/A Recruiting May 7, 2026

Closed-loop TMS for Tremor

Trial N/A Recruiting May 6, 2026

O-ARM Stereotactic Imaging in Deep Brain Stimulation for Parkinson's Disease

Trial N/A Completed May 6, 2026

Pathophysiology of Neuronal Oscillations Within Subthalamo-cortical Loops in Parkinson's Disease

Trial N/A Completed May 6, 2026

Effects of RAS on Gait in PD Patients With DBS

Trial N/A Recruiting May 5, 2026

Combined Deep Brain Stimulation in Parkinson's Disease

Trial N/A Completed May 5, 2026

A Prospective, Randomized, Controlled Trial to Test Safety and Effectiveness of Unilateral Exablate MR-guided Focused Ultrasound Subthalamotomy in Patients With Early-Stage Parkinson's Disease

Trial N/A Active, not recruiting May 5, 2026

Therapeutic Education in Parkinson's Disease: What Impact on Drug Representations of Patients? (ETPARK-REMED)

Trial N/A Completed May 5, 2026

Functional Neuroimaging in Parkinson's Disease

Trial N/A Completed May 5, 2026

Exenatide Once Weekly Over 2 Years as a Potential Disease Modifying Treatment for Parkinson's Disease

Trial Phase 3 Completed May 5, 2026

Attention and Eye Movement in Parkinson's Disease

Trial N/A Recruiting May 4, 2026

Reliability and Validity of Sensor-derived Measurements in Individuals With Parkinson's Disease: Preliminary Results From the INERTIAL Study

Trial N/A Completed May 4, 2026

Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Disease

Trial Phase 2 Completed May 3, 2026

Enrichment of Glutathione Using Gamma-glutamylcysteine Supplementation in Parkinson's Disease Patients.

Trial Phase 1 Recruiting May 3, 2026

Robotic Gait Rehabilitation in Parkinson's Disease

Trial N/A Terminated May 3, 2026

" Visual Characterization of Parkinson's Patients and Oculomotor or Perceptual Therapy"

Trial N/A Completed May 3, 2026

Evaluation of Neuroinflammation in Parkinson's Disease Using 18F-NOS PET/CT

Trial Early Phase 1 Active, not recruiting April 30, 2026